In-vitro Colorectal Cancer Screening Tests Market to Grow with a CAGR of 3.04% through 2029

Increase in the incidence of Colorectal Cancer and increase in the aging population is expected to drive the Global In-vitro Colorectal Cancer Screening Tests Market growth in the forecast period, 2025-2029.

 

According to TechSci Research report, “In-vitro Colorectal Cancer Screening Tests Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global In-vitro Colorectal Cancer Screening Tests Market stood at USD 864.60 million in 2023 and is anticipated to grow with a CAGR of 3.04% in the forecast period, 2025-2029. The awareness among individuals regarding In-vitro Colorectal Cancer Screening Tests has led to favorable market conditions for the global In-vitro Colorectal Cancer Screening Tests market. Several factors contribute to the growth of various In-vitro Colorectal Cancer Screening Tests products.

Colorectal cancer is one of the most prevalent and deadly types of cancer worldwide. The growing incidence and mortality rates associated with colorectal cancer have led to increased awareness and the need for regular screening. According to the World Cancer Research Fund, colorectal cancer is the third most commonly diagnosed cancer globally. The rising burden of this disease has prompted healthcare organizations and governments to encourage colorectal cancer screening, which, in turn, drives the demand for in-vitro screening tests.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global In-vitro Colorectal Cancer Screening Tests Market”

Advancements in in-vitro diagnostic technologies have significantly improved the accuracy and convenience of colorectal cancer screening. These advancements include the development of more sensitive and specific biomarkers, genetic and molecular markers utilization, and the introduction of non-invasive or minimally invasive screening methods like blood tests and stool-based tests. These cutting-edge technologies not only enhance the diagnostic process but also make screening more accessible to a wider population.

Colorectal cancer primarily affects individuals aged 50 and older, and with the global population aging, there is a growing demographic for colorectal cancer screening. Healthcare providers are increasingly emphasizing early detection among older individuals, which is expected to further drive market growth.

In today's fast-paced world, in-vitro colorectal cancer screening tests offer convenience and minimal preparation. Patients can easily collect samples at home, eliminating the need for lengthy hospital visits or extensive bowel preparation. This convenience is especially beneficial for individuals with busy schedules who may find it difficult to take time off for screening. In-vitro tests are generally quicker than traditional methods like colonoscopies, making them more time-efficient for both patients and healthcare providers. These screening tests are widely accessible and can be performed at various healthcare facilities, clinics, or even at home, which is essential for individuals with limited access to specialized medical centers due to their schedules or geographic location.

Governments and healthcare organizations worldwide have recognized the importance of colorectal cancer screening in reducing disease burden and healthcare costs, leading to various initiatives and public health campaigns to promote awareness and early detection. In-vitro screening tests such as fecal occult blood tests (FOBTs) offer a cost-effective solution compared to alternative methods like colonoscopies. Their affordability makes them attractive for both healthcare providers and payers, ensuring viability for a wide range of patients, including those within resource-limited healthcare systems. Additionally, the non-invasive nature of FOBTs encourages higher patient compliance and mitigates barriers associated with fear or discomfort.

In terms of regional distribution, North America, particularly the United States and Canada, has one of the highest rates of colorectal cancer prevalence globally, driving demand for screening tests. The region benefits from a robust healthcare infrastructure and public awareness initiatives, facilitating accessibility to screening programs.

The Asia-Pacific market presents significant growth opportunities due to its sizable yet underserved population, rising awareness of colorectal cancer, and increasing investments in healthcare infrastructure. Shifts in lifestyle and dietary habits contribute to an elevated risk of colorectal cancer, further driving demand for screening tests in the region.

 

Major companies operating in Global In-vitro Colorectal Cancer Screening Tests Market are:

• Abbott Laboratories, Inc.
• Beckman Coulter, Inc.
• Eiken Chemical Co., Ltd.
• Sysmex Corporation
• Siemens Healthineers AG
• Quest Diagnostics Incorporated
• Merck KGaA
• Kyowa Kirin Co., Ltd.
• Randox Laboratories Ltd.
• R-Biopharm AG

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The Advancements in Screening Technologies and increasing Colorectal Cancer Incidence and Mortality Rates are key drivers of the In-vitro Colorectal Cancer Screening Tests market. In recent years, the growing Government-sponsored initiatives and public health campaigns play a pivotal role in raising awareness about colorectal cancer and promoting regular screening. These campaigns often lead to higher screening rates and demand for in-vitro tests. To meet the demands of the market, manufacturers are increasingly incorporating cutting-edge technologies with high production efficiency. Rising consumer acceptance and continuous product innovation will further ensure the growth of the In-vitro Colorectal Cancer Screening Tests market in the coming years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“In-vitro Colorectal Cancer Screening Tests Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Test Type (Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests), By Region, Competition 2019-2029F”, has evaluated the future growth potential of Global In-vitro Colorectal Cancer Screening Tests Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global In-vitro Colorectal Cancer Screening Tests Market.

 

Contact Us-

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Website: www.techsciresearch.com